Seminars in oncologyHumansBiomarkersTumorCarcinomaNon-Small-Cell Lung
Pretreatment eosinophilia as a biomarker for adverse outcomes in non-small cell lung cancer patients receiving immune checkpoint inhibitors: A systematic review and meta-analysis.
Nency Ganatra, Jacob Thompson, Rupak Desai, Jinish Doshi, Pragya Jain, Diksha Sanjana Pasnoor, Akhil Jain
Published: 202510.1016/j.seminoncol.2025.152431
Abstract
In recent years, immune checkpoint inhibitors (ICIs) have transformed the therapeutic landscape of non-small cell lung cancer (NSCLC), yet treatment response and adverse events vary widely among patients. In response, the identification of reliable p…
Preview only. Read the full abstract at the source